The Opportunity 2018-01-05T16:10:51+00:00

The Opportunity

Female urinary incontinence (UI) is a global problem affecting 1 in 3 women across a range of age spectrums.

Female urinary incontinence is a one of the most prevalent conditions in female health, affecting approximately 1/3 of all women.

A global issue with average incidence rates across all age bands principally starting from post childbirth, increasing post menopause, and through to older age.

European Hunskaar study confirmed a 35% incidence

Sufferer penetration & by UI type

Incontinence type by age band

Current solutions and interventions include panty liners, incontinence pads, mechanical devices and pessaries. These manage symptoms and fail to treat the underlying condition. Other solutions are drug treatments all with side effects and surgery, the last resort for the majority of females and only suitable for small percentage of target patients.

Pelviva®

  • An active treatment for incontinence
  • A non-prescription medical device
  • Available direct to the consumer
  • Potential treatment solution for 698 million women worldwide